Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details 1) - USD ($)	Feb. 28, 2023	Aug. 31, 2022
Net Balance	$ 301,421	$ 315,505
US [Member]
Net Balance	127,880	100,031
Cost	140,487	98,050
Addition	33,748	42,375
Leasehold Improvements [Member]
Net Balance	38,277	65,296
Leasehold Improvements [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Furniture Fixtures Equipment [Member]
Net Balance	5,079	8,289
Furniture Fixtures Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Lab Equipment [Member]
Net Balance	251,074	232,563
Lab Equipment [Member] \| US [Member]
Net Balance	127,880	100,031
Cost	140,487	98,050
Addition	33,748	42,375
Computer Equipment [Member]
Net Balance	6,991	9,357
Computer Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Canada [Member]
Net Balance	173,541	215,475
Cost	555,073	548,256
Addition	0	6,817
Canada [Member] \| Leasehold Improvements [Member]
Net Balance	38,277	65,296
Cost	259,981	259,981
Addition	0	0
Canada [Member] \| Furniture Fixtures Equipment [Member]
Net Balance	5,079	8,289
Cost	31,126	31,126
Addition	0	0
Canada [Member] \| Lab Equipment [Member]
Net Balance	123,194	132,533
Cost	193,185	193,185
Addition	0	0
Canada [Member] \| Computer Equipment [Member]
Net Balance	6,991	9,357
Cost	70,781	63,964
Addition	$ 0	$ 6,817